Solid Tumors
A Phase 1 Basket Study Evaluating the Safety and Feasibility of T-Plex, Autologous Customized T Cell Receptor-Engineered T Cells Targeting Multiple Peptide/HLA Antigens in Participants with Antigen-positive Locally Advanced (Unresectable) or Metastatic Solid Tumors: PLEXI-T TM (TSCAN-002)
- Details
ClinicalTrials.gov ID:
NCT05973487
Diagnosis Type:
NA
USOR Number:
- Address
,
P: